US10695471B2 - Wound dressing apparatus - Google Patents
Wound dressing apparatus Download PDFInfo
- Publication number
- US10695471B2 US10695471B2 US14/378,309 US201314378309A US10695471B2 US 10695471 B2 US10695471 B2 US 10695471B2 US 201314378309 A US201314378309 A US 201314378309A US 10695471 B2 US10695471 B2 US 10695471B2
- Authority
- US
- United States
- Prior art keywords
- dome
- wound
- manifold
- passage
- interior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000004891 communication Methods 0.000 claims abstract description 23
- 230000002093 peripheral effect Effects 0.000 claims description 19
- 239000000853 adhesive Substances 0.000 claims description 13
- 230000001070 adhesive effect Effects 0.000 claims description 13
- 210000001367 artery Anatomy 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 8
- 229920002379 silicone rubber Polymers 0.000 claims description 3
- 239000004945 silicone rubber Substances 0.000 claims description 2
- 239000012530 fluid Substances 0.000 abstract description 33
- 238000011282 treatment Methods 0.000 abstract description 33
- 206010052428 Wound Diseases 0.000 description 146
- 208000027418 Wounds and injury Diseases 0.000 description 145
- 238000002560 therapeutic procedure Methods 0.000 description 26
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 23
- 239000001301 oxygen Substances 0.000 description 23
- 229910052760 oxygen Inorganic materials 0.000 description 23
- 238000002639 hyperbaric oxygen therapy Methods 0.000 description 13
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 8
- 238000000034 method Methods 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 230000029663 wound healing Effects 0.000 description 5
- 230000001684 chronic effect Effects 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229920002444 Exopolysaccharide Polymers 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000004210 Pressure Ulcer Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 238000009581 negative-pressure wound therapy Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 108010059993 Vancomycin Proteins 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- -1 hypochlorous acid compound Chemical class 0.000 description 1
- 230000001146 hypoxic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 229960003165 vancomycin Drugs 0.000 description 1
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 1
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
- A61M1/85—Drainage tubes; Aspiration tips with gas or fluid supply means, e.g. for supplying rinsing fluids or anticoagulants
-
- A61M1/0088—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00068—Accessories for dressings specially adapted for application or removal of fluid, e.g. irrigation or drainage of wounds, under-pressure wound-therapy
-
- A61F13/05—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H9/00—Pneumatic or hydraulic massage
- A61H9/005—Pneumatic massage
- A61H9/0057—Suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
- A61H9/00—Pneumatic or hydraulic massage
- A61H9/005—Pneumatic massage
- A61H9/0078—Pneumatic massage with intermittent or alternately inflated bladders or cuffs
-
- A61M1/0084—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/912—Connectors between dressing and drainage tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/91—Suction aspects of the dressing
- A61M1/915—Constructional details of the pressure distribution manifold
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/92—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with liquid supply means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/90—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing
- A61M1/94—Negative pressure wound therapy devices, i.e. devices for applying suction to a wound to promote healing, e.g. including a vacuum dressing with gas supply means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/30—Gas therapy for therapeutic treatment of the skin
-
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/042—Force radial
- F04C2270/0421—Controlled or regulated
Definitions
- the present disclosure relates to a wound dressing apparatus for use in wound care treatment. More particularly, the present disclosure pertains to a wound dressing apparatus for providing combined negative and positive pressure treatment to a wound site.
- Conventional treatments for chronic wounds typically include negative pressure therapy and/or hyperbaric oxygen therapy.
- Negative pressure therapy is the controlled application of sub-atmospheric pressure to a wound using a therapy unit, such as a vacuum or suction device, to expose the wound to negative pressure to help promote wound healing.
- a therapy unit such as a vacuum or suction device
- the wound is typically covered to facilitate the application of negative pressure and suction at the wound area.
- Various types of resilient, open cell foam surface dressings are typically sealed within an adhesive drape to provide the sub-atmospheric pressure at the wound site. Exudates are drained from the wound site and typically directed to a canister that stores the fluids and/or infectious material until properly disposed.
- Negative pressure wound therapy is often prescribed for chronic and acute wound types such as diabetic wounds, pressure ulcers, abdominal wounds, trauma wounds, various burns, flaps and grafts.
- negative pressure therapy may be less effective on patients having vascular disorders, such as diabetes, because negative pressure therapy can create a hypoxic environment at the wound.
- portable vacuum pumps are often rented or purchased for the purpose of providing negative pressure therapy. This can significantly increase the cumulative costs of providing wound care.
- Hyperbaric oxygen therapy is the controlled application of oxygen to a wound at greater-than-atmospheric pressure(s).
- Oxygen is typically required for all new cell growth. Chronic or non-healing wounds tend to exhibit low oxygen tensions, or tend to be ischemic. A wound can become dormant if the amount of poorly oxygenated wound tissue reaches a critical mass. In this state, the body may no longer recognize the need to heal the affected area, thereby exacerbating the lack of oxygen in the wound and impairing healing of the wound by the body.
- Oxygen therapy is particularly useful for patients with poor circulation. The oxygen helps to kill bacteria and when applied to an open wound at a hyperbaric level, the oxygen is dissolved into the wound and absorbed by the surface wound tissue.
- oxygen may act as a primary wound treatment fluid
- hyperbaric oxygen therapy is delivered by placing the patient in a hyperbaric chamber that encompasses the full body of the patient or an entire extremity, such as a leg or an arm.
- a hyperbaric chamber that encompasses the full body of the patient or an entire extremity, such as a leg or an arm.
- Such chambers are problematic due to their lack of portability, the difficulty in sterilization of the chambers between patients, and the potential adverse effects of breathing oxygen at hyperbaric pressure.
- hyperbaric oxygen treatment should be localized at the wound site rather than applied to the patient's entire body or extremity.
- wound care systems and methods have been developed that combine negative and positive pressure (e.g. hyperbaric oxygen) wound treatment therapies.
- Such methods and systems are described, for example, in U.S. Pat. No. 7,648,488, issued Jan. 19, 2010; U.S. Pat. No. 8,357,130, issued Jan. 22, 2013; U.S. Patent Publication No. 2008/0140029; and U.S. Patent Publication No. 2010/0121287.
- Wound care treatment may be further enhanced by deactivating pathogenic microorganisms within the wound environment and physically removing the deactivated microorganisms and other toxins from the wound site. While antibiotics and other drugs may be effective in destroying bacteria and other pathogens, their activity may disrupt the cell walls of the microorganisms, thereby releasing harmful enzymes and other toxins into the wound environment. These harmful enzymes and toxins must be removed or they may become cytotoxic.
- Biofilms are held together and protected by a matrix of excreted polymeric compounds called EPS (exopolysaccharide).
- EPS excreted polymeric compounds
- Biofilms provide a protective environment for microorganisms that exist within the biofilm mass and a level of immunity from antibiotic treatments, except in doses that would be fatal to the patient. Consequently, biofilm microorganisms are not affected by the body's own infection-resistance mechanisms.
- bacterial biofilms may impair cutaneous wound healing and reduce topical antibacterial efficiency in healing or treating infected skin wounds.
- Hypochlorous acid is an active component found in the human immune system as a natural defense against infection, and thus kills bacteria, fungi and viruses without creating mechanisms for drug resistance.
- Hypochlorous acid compounds can be a safe, fast acting, broad spectrum antimicrobial for topical application, effective against all groups of hydrophobic, hydrophilic, gram-negative and gram-positive bacteria, and yeast, including Pseudomonas aeruginosa, Staphylococcus aureus , and multi-drug resistant organisms like methicillin resistant Staphylococcus aureus (MRSA), and vancomycin resistant enterococci (VRE).
- MRSA methicillin resistant Staphylococcus aureus
- VRE vancomycin resistant enterococci
- hypochlorous acid compounds rapidly penetrate and disrupt biofilm and eradicate the pathogens, the major factor that inhibits wound healing. Unlike most antibiotics, which can take many hours to work, hypochlorous acid compounds, even at small doses, can help eradicate bacteria, fungi and viruses in minutes. When applied topically within a wound environment, hypochlorous acid compounds immediately disrupt and eradicate the bio-film, which surrounds and deactivates a broad spectrum of pathogenic microorganisms. Hypochlorous acid generally controls the tissue bacterial bio-burden without inhibiting the wound healing process and is also commonly associated with improved wound closure. Accordingly, a wound treatment therapy using a stabilized hypochlorous acid compound has recently been disclosed in U.S. Patent Publication No. 2012/0328680, the entirety of which is hereby incorporated by reference.
- a wound dressing that can deliver one or more different wound therapies to a wound site.
- the wound treatment apparatus of the present invention may provide, using a unitary dressing apparatus, both negative pressure wound therapy and positive pressure (hyperbaric oxygen) wound therapy to a wound site.
- An embodiment of the invention includes a wound dressing comprising a domed chamber having a chamber wall defining a dome apex, a peripheral edge, and a substantially hollow dome interior; a flange extending away from the peripheral edge of the domed chamber; a manifold within the domed chamber, the manifold comprising a plurality of apertures in communication with the dome interior; a first passage having a first end adapted to connect to a negative pressure source and a second end in communication with the dome interior; and a second passage having a first end adapted to connect to a positive pressure source and a second end in communication with the manifold.
- the manifold is formed integrally with the domed chamber and/or with the flange.
- the manifold has an annular shape.
- the first passage may extend partially across the chamber wall. Further, the second end of the first passage may connect proximate to the apex of the domed chamber. Additionally, a portion of the first passage and/or a portion of the second passage may be formed integrally with the domed chamber.
- the wound dressing apparatus may comprise a pliable material, such as silicone rubber.
- the wound dressing apparatus may have an adhesive provided on at least a portion of the flange. In certain embodiments, the adhesive is effective to create a seal between the flange and a wound drape.
- the wound dressing apparatus may include a domed chamber having a chamber wall defining a dome apex, a peripheral edge, and a dome interior; a flange extending away from the peripheral edge of the domed chamber; a manifold formed within the domed chamber, the manifold comprising a plurality of channels in communication with the dome interior; a first passage having a first end adapted to connect to a negative pressure source, the first passage comprising a plurality of channels in communication with the dome interior; and a second passage having a first end adapted to connect to a positive pressure source and a second end in communication with the manifold.
- the channels of the manifold are arranged in a fractal pattern. Further, the channels of the first passage may also be arranged in a fractal pattern.
- Certain embodiments of the apparatus include a manifold that is formed integrally with the domed chamber, and the manifold may span the circumference of the dome interior.
- the wound dressing apparatus may take form in various arrangements of components.
- the drawings are provided herewith only for purposes of illustrating exemplary embodiments and are not to be construed as limiting the scope of the present disclosure or of the claims appended hereto.
- the drawings illustrate embodiments of the wound dressing apparatus, in which:
- FIG. 1 is a perspective view of an embodiment of the wound dressing apparatus.
- FIG. 3 is a side sectional view of the wound dressing apparatus taken along line 3 - 3 of FIG. 2 ;
- FIG. 4 is a sectional view of the wound dressing taken along line 4 - 4 of FIG. 2 ;
- FIG. 5 is an end sectional view of the wound dressing apparatus taken along line 5 - 5 of FIG. 2 ;
- FIG. 6 is a perspective view of the wound dressing apparatus as applied to a wound site on a human leg.
- FIG. 7 is a perspective view of the wound dressing apparatus as applied to a wound site on a human leg.
- FIG. 8 is a top view of another embodiment of the wound dressing apparatus.
- FIG. 9 is a side sectional view of the wound dressing taken along line 9 - 9 of FIG. 8 ;
- FIG. 10 is a sectional view of the wound dressing taken along line 10 - 10 of FIG. 8 ;
- FIG. 11 is an end sectional view of the wound dressing taken along line 11 - 11 of FIG. 8 .
- the device(s) of the present disclosure can comprise, consist of, or consist essentially of the essential elements and limitations of the embodiments described herein, as well as any additional or optional components or limitations described herein or otherwise useful in wound healing application(s).
- the term(s) “about” or “approximately” should be construed to include both of the numbers specified as the endpoint(s) of any range. Furthermore, any reference to a range should be considered as providing support for any subset within that range.
- negative pressure should be construed to include any pressure less than ambient pressure at a wound site. Generally, the negative pressure will be less than the atmospheric pressure at which a patient is located.
- positive pressure should be construed to include any pressure greater than ambient pressure at a wound site. Generally, the positive pressure will be greater than the atmospheric pressure at which a patient is located.
- fluid should be construed to include any substance lacking a fixed shape, including, but not limited to, any liquid and/or any gas.
- the term “manifold” should be construed to include a structure or substance that includes one or more channels, passages and/or pathways for distributing fluid.
- fractal pattern should be construed to include any geometry or design wherein the similar or identical geometry or design is followed through each branch of the successive stage(s) or division(s) of a branched network.
- fractal region of “fractal pattern” may include equal numbers of bifurcations and junctions disposed serially along a channel, artery, passage and/or pathway in a direction of fluid flow.
- FIGS. 1-7 illustrate an embodiment of the wound dressing apparatus, which is designated generally as reference numeral 10 .
- a wound dressing apparatus can be employed, for example, whenever a controlled distribution and/or collection of fluid(s) is desired. Further, the wound dressing apparatus can be employed whenever combined negative and positive pressure therapy treatment is desired at a wound site.
- Wound dressing 10 facilitates both negative pressure wound treatment and positive pressure (hyperbaric) wound treatment at a wound site 2 . Further, wound dressing 10 facilitates combined negative pressure therapy and positive pressure therapy at wound site 2 .
- Wound dressing 10 covers and hermetically seals wound site 2 and facilitates the wound treatment in accordance with the principles and teachings of the wound care system, as described in U.S. Pat. No. 6,648,488 issued Jan. 19, 2010, and U.S. patent application Ser. No. 12/688,485 filed Jan. 15, 2010, and U.S. patent application Ser. No. 12/033,558 filed Feb. 19, 2008, which are all hereby incorporated in their entirety by reference.
- wound dressing 10 includes a wound dome 20 .
- Wound dome 20 may be formed, molded or otherwise made of a pliable material.
- the pliable material may be a material suitable for medical purposes, such as a silicon rubber or Arkema Pebax® polymer.
- Wound dome 20 is configured to have a domed center chamber 22 .
- the domed chamber includes a chamber wall defining a dome apex and a substantially hollow dome interior 21 .
- the wound dome 20 has a peripheral edge and a flange 24 .
- the domed center chamber 22 further includes an opening 33 at or proximate to the apex.
- domed center chamber 22 may include ribs on the peripheral side wall.
- flange 24 extends away from a peripheral edge of the domed center chamber 22 .
- the flange is flat in some embodiments of the wound dressing apparatus.
- an adhesive may be provided on at least a portion of a surface of the flange.
- Wound dome 20 may have one or more lumen connectors 30 and 32 .
- the wound dressing apparatus includes a pair of lumen connectors 30 and 32 .
- the lumen connector(s) may be formed integrally with the dome 20 .
- Lumen connectors 30 and 32 are in open communication with a first passage 31 and with a second passage 35 .
- Lumen connector 30 is adapted to connect to a negative pressure supply and/or a drain line so that the negative pressure draws exudate into fluid passage 31 through opening 33 of domed center 22 .
- the negative pressure supply may be, for example, a therapy unit, such as a vacuum or suction device.
- Lumen connector 32 is connected to a positive pressure supply and/or to a fluid delivery system and/or to a supply line so that delivered fluids are dispersed radially into the wound site through apertures 39 in manifold 37 .
- hypochlorous acid, medications and disinfectants may be introduced into the positive pressure fluid flow and delivered to the wound site through the wound dressing apparatus.
- the wound dressing apparatus engages a supply line connected to a fluid source and a drain line connected to a negative pressure source. Negative pressure therapy may be administered to a wound site via the supply line, and hyperbaric fluid therapy may be administered to a wound via the supply line.
- first passage 31 may be formed integrally with domed chamber 22 .
- second passage 35 may be formed integrally with domed chamber 22 .
- a portion of first passage 31 and/or a portion of second passage 35 may be formed in the wall of domed chamber 22 .
- a first end of first passage 31 may be adapted to connect to a negative pressure source and/or to lumen connector 30 .
- a second end of first passage 31 is in open communication with the dome interior 21 and may be connected proximate to the apex of the domed chamber 22 .
- First passage 31 may be adapted or arranged to extend across a portion of the dome chamber 22 , as shown in FIG. 1 and in FIG. 3 .
- first fluid passage 31 extends from lumen connector 30 to the apex of domed center 22 and terminates in an opening 33 that is in open communication with the interior 21 of wound dome 20 , as shown in FIGS. 1, 2 and 3 .
- First passage 31 may comprise a plurality of fluid channels, arteries or pathways 102 that are in communication with the dome interior 21 , as shown in FIG. 9 and in FIG. 11 .
- the channels 102 of first passage 31 may be arranged in a fractal pattern.
- a first end of second passage 35 may be adapted to connect to a positive pressure source and/or to lumen connector 32 .
- a second end of second passage 35 is in open communication with the manifold 37 .
- Second passage 35 may be adapted or arranged to extend across a portion of the domed chamber 22 .
- second passage 35 extends laterally from lumen connector 32 across dome center 22 to the manifold 37 , as shown in FIG. 4 .
- the structure of second passage 35 extending laterally over the domed center 22 from one side to the other lends structural integrity to the domed center, which helps prevent wound dome 20 from collapsing during negative pressure wound treatment.
- Wound dome 20 also has a fluid manifold 37 that may be integrally formed with or between the bottom peripheral edge of domed center 22 and/or flange 24 .
- the manifold 37 may have an annular shape, which may be similar to the shape of the domed center 22 .
- manifold 37 has a plurality of apertures 39 that may be spaced along its length, as shown in FIGS. 2 and 3 . The apertures allow for open fluid communication between the manifold and the dome interior 21 . Further, the apertures allow fluid to be dispersed radially into the wound site through the manifold 37 .
- the manifold 37 ′ may include a plurality of branching channels, arteries or pathways 104 that are adapted to allow for open fluid communication between the manifold and the dome interior.
- the branching channels 104 may be formed integrally with the wall of the domed center 22 ′.
- the branching channels 104 of the manifold may be arrange in a fractal pattern.
- the manifold 37 or 37 ′ has an annular shape, and its length may span the circumference of the domed center 22 and/or of the dome interior 21 , as shown in FIGS. 2 and 8 .
- wound domed 20 may be sandwiched between two sealing drapes 40 and 50 when applied to a wound site 2 .
- Sealing drapes 40 and 50 are of conventional design and construction, well known in the medical arts and are generally thin sheets of at least one sterile material that is not air permeable.
- each drape 40 and 50 may have an adhesive 42 and 52 on at least a portion of its surface.
- adhesive is applied to at least a portion of a bottom surface of drape 40 and/or drape 50 .
- the adhesive 42 and 52 may be covered by a disposable covering film 46 and 56 , respectively.
- Each of drapes 40 and 50 may be provided with a central opening, as shown in FIGS. 6 and 7 , or the drape(s) may be cut to create opening(s) therein, as shown in FIG. 1 .
- Drape 40 may be fitted over the wound site 2 with the drape opening 41 exposing the wound site. Drape 40 is secured to a subject's skin by its adhesive 42 .
- Wound dome 20 is placed over wound site 2 so that flange 24 contacts drape 40 .
- An adhesive may be applied to at least a portion of flange 24 , as desired, to seal and secure the flange to drape 40 .
- the bottom of flange 24 is coated with an adhesive.
- Drape 50 is placed over wound dome 20 so that domed center 22 extends through drape opening 51 , as shown in FIGS. 6 and 7 . Drape 50 is secured around wound dome 20 and to drape 40 by its adhesive bottom 52 . Once wound dressing 10 is in place over wound site 2 , the negative pressure lumen and positive pressure lumen are then connected to lumen connections 30 and 32 .
- FIGS. 8-11 illustrate an alternate embodiment of the wound dressing apparatus.
- the alternate embodiment is designated as reference numeral 100 .
- wound dressing 100 is configured to have a domed center chamber 22 ′, including a chamber wall defining a dome apex, a substantially hollow dome interior, a peripheral edge, and a flange 24 ′.
- Wound dressing 100 employs principles of fractal fluid dynamics.
- first fluid passage 31 ′ extends across a portion of the dome center chamber 22 ′ and opens at or proximate to the apex of domed center 22 ′ into a series of smaller branching arteries 102 formed in the wall of domed center 22 ′.
- manifold 37 ′ has a plurality of branching arteries 104 formed in the wall of the domed center 22 ′. As shown in FIG. 10 , second passage 35 ′ is in communication with manifold 37 ′. Both sets of branching arteries are configured using fractal fluid dynamics to optimize fluid flow to first fluid passage 31 ′ or manifold 37 ′. Each set of branching arteries 102 and 104 may be arranged in a fractal pattern.
- the wound dressing apparatus is configured to provide both negative pressure wound treatment and positive pressure (e.g., hyperbaric oxygen) treatment to a wound site.
- the wound dressing apparatus may cover a wound site and may hermetically seal the wound site and facilitate the wound treatment.
- the negative pressure and hyperbaric oxygen therapies may be delivered at therapeutic levels via a wound dressing apparatus using one or more operational modes.
- therapeutically effective levels of hyperbaric oxygen and negative pressure treatments may be affected by different combinations of fluid pressures, fluid concentrations, fluid flow rates, treatment durations, and treatment intervals, as is known in the art.
- therapeutically effective wound treatment levels and wound treatment protocols can be determined generally in accordance with the methods and principles and described in U.S. Pat. Nos. 7,648,488, 8,357,130, U.S. Patent Publication No. 2008/0140029, and U.S. Patent Publication No. 2010/0121287, all of which are hereby incorporated in their entirety by reference.
- An example of a wound treatment protocol combining the application of negative pressure and hyperbaric oxygen treatments can include administering hyperbaric oxygen therapy to the wound in a range of approximately 8 minutes to approximately 12 minutes and administering negative pressure therapy to the wound at less than 1 atmosphere for approximately 8 minutes to approximately 12 minutes.
- the wound treatment cycle times and ranges may vary according to the nature and severity of the wound being treated and according to the wound response to the treatment.
- the hyperbaric oxygen therapy and the negative pressure therapy are administered intermittently such that negative pressure therapy is administered immediately following the administration of hyperbaric oxygen therapy and hyperbaric oxygen therapy is administered immediately following the administration of negative pressure therapy.
- the wound may be subject to an absolute pressure of from approximately 60 mmHg to approximately 160 mmHg during the administration of negative pressure therapy.
- Administering hyperbaric oxygen therapy may include supplying oxygen or humidified oxygen to the wound at a flow rate of approximately 0.1 liters per minute to approximately 3 liters per minute.
- the wound dressing apparatus facilitates both an internal negative pressure and a positive pressure wound therapy at a wound site.
- the wound dressing apparatus includes a pliable wound dome configured to have a hollow domed center, a flat integral peripheral flange and one or more integral lumen connectors.
- the lumen connectors are in open communication with two fluid passages that are formed within the walls of the domed center.
- An annular fluid manifold is integrally formed between the bottom edge of the domed center and the peripheral flange.
- a fluid passage may extend laterally across the dome center where it opens into the annular manifold.
- the manifold has a plurality of apertures spaced along its length, which allows for the even, radial delivery of fluid into the wound site.
- Another fluid passage extends partly over the dome center but terminates in an opening at the apex of the domed center, which allows fluids to be drawn radially from the center of the wound dome.
Abstract
Description
Claims (18)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/378,309 US10695471B2 (en) | 2012-02-13 | 2013-02-13 | Wound dressing apparatus |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261633509P | 2012-02-13 | 2012-02-13 | |
PCT/US2013/025875 WO2013123005A1 (en) | 2012-02-13 | 2013-02-13 | Wound dressing apparatus |
US14/378,309 US10695471B2 (en) | 2012-02-13 | 2013-02-13 | Wound dressing apparatus |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2013/025875 A-371-Of-International WO2013123005A1 (en) | 2012-02-13 | 2013-02-13 | Wound dressing apparatus |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/917,072 Continuation US11517655B2 (en) | 2012-02-13 | 2020-06-30 | Wound dressing apparatus |
Publications (2)
Publication Number | Publication Date |
---|---|
US20150005678A1 US20150005678A1 (en) | 2015-01-01 |
US10695471B2 true US10695471B2 (en) | 2020-06-30 |
Family
ID=48984647
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/378,309 Active 2033-03-26 US10695471B2 (en) | 2012-02-13 | 2013-02-13 | Wound dressing apparatus |
US16/917,072 Active 2033-06-02 US11517655B2 (en) | 2012-02-13 | 2020-06-30 | Wound dressing apparatus |
US18/076,181 Pending US20230173162A1 (en) | 2012-02-13 | 2022-12-06 | Wound dressing apparatus |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/917,072 Active 2033-06-02 US11517655B2 (en) | 2012-02-13 | 2020-06-30 | Wound dressing apparatus |
US18/076,181 Pending US20230173162A1 (en) | 2012-02-13 | 2022-12-06 | Wound dressing apparatus |
Country Status (5)
Country | Link |
---|---|
US (3) | US10695471B2 (en) |
EP (1) | EP2814556B1 (en) |
CA (1) | CA2864414C (en) |
DK (1) | DK2814556T3 (en) |
WO (1) | WO2013123005A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11517655B2 (en) * | 2012-02-13 | 2022-12-06 | Phase One Health, Llc | Wound dressing apparatus |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7909805B2 (en) | 2004-04-05 | 2011-03-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US8062272B2 (en) | 2004-05-21 | 2011-11-22 | Bluesky Medical Group Incorporated | Flexible reduced pressure treatment appliance |
US10058642B2 (en) | 2004-04-05 | 2018-08-28 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
GB0723872D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Apparatus for topical negative pressure therapy |
US8298200B2 (en) | 2009-06-01 | 2012-10-30 | Tyco Healthcare Group Lp | System for providing continual drainage in negative pressure wound therapy |
ES2658263T3 (en) | 2008-08-08 | 2018-03-09 | Smith & Nephew, Inc. | Continuous fiber wound dressing |
AU2011345328B2 (en) | 2010-12-22 | 2016-03-10 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
HUE047600T2 (en) | 2012-05-23 | 2020-04-28 | Smith & Nephew | Apparatuses for negative pressure wound therapy |
AU2013298195B2 (en) | 2012-08-01 | 2017-07-13 | Smith & Nephew Plc | Wound dressing |
EP4112020A1 (en) | 2012-08-01 | 2023-01-04 | Smith & Nephew plc | Wound dressing and method of treatment |
EP3677291B1 (en) | 2013-05-10 | 2024-01-03 | Smith & Nephew PLC | Fluidic connector for irrigation and aspiration of wounds |
US20150196694A1 (en) * | 2013-12-02 | 2015-07-16 | C. Edward Eckert | Directional Bandage for Delivering Oxygenated Solution to Wound and Method of Treating a Wound Using Same |
US10076594B2 (en) | 2015-05-18 | 2018-09-18 | Smith & Nephew Plc | Fluidic connector for negative pressure wound therapy |
USD806255S1 (en) * | 2016-10-07 | 2017-12-26 | 3M Innovative Properties Company | Medical dressing |
USD806882S1 (en) * | 2016-10-07 | 2018-01-02 | 3M Innovative Properties Company | Medical dressing |
US20180289556A1 (en) | 2017-04-11 | 2018-10-11 | Ipcapital Group, Inc. | Wound covering apparatus |
US20190030226A1 (en) * | 2017-07-29 | 2019-01-31 | Edward D. Lin | Augmented pressure therapy for wounds |
US11712373B2 (en) | 2017-07-29 | 2023-08-01 | Edward D. Lin | Wound therapy apparatus with scar modulation properties and related methods |
US10729826B2 (en) | 2017-07-29 | 2020-08-04 | Edward D. Lin | Wound cover apparatus and related methods of use |
US11559622B2 (en) * | 2017-07-29 | 2023-01-24 | Edward D. Lin | Deformation resistant wound therapy apparatus and related methods of use |
US10780201B2 (en) | 2017-07-29 | 2020-09-22 | Edward D. Lin | Control apparatus and related methods for wound therapy delivery |
CN111050711B (en) * | 2017-07-29 | 2022-05-27 | 林正纶 | Anti-deformation wound treatment devices and related methods of use |
GB201718014D0 (en) | 2017-11-01 | 2017-12-13 | Smith & Nephew | Dressing for negative pressure wound therapy with filter |
WO2019191077A1 (en) * | 2018-03-26 | 2019-10-03 | Deroyal Industries, Inc. | Multi-lumen bridge for negative pressure wound therapy system |
GB201811449D0 (en) | 2018-07-12 | 2018-08-29 | Smith & Nephew | Apparatuses and methods for negative pressure wound therapy |
US20200289376A1 (en) | 2019-03-15 | 2020-09-17 | Mitera LLC | Nipple Shield with Port and Flap-Covered Channel to Supplement Lactation During Breastfeeding |
USD914892S1 (en) * | 2019-03-15 | 2021-03-30 | Mitera LLC | Nipple shield |
USD951428S1 (en) * | 2020-05-11 | 2022-05-10 | Xiamen Suneetek Medical Equipment Co., Ltd. | Suction disk for negative pressure wound therapy |
US20220047427A1 (en) * | 2020-08-16 | 2022-02-17 | Joe Brantzeg | Wound Covering Device |
Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2280915A (en) * | 1941-04-03 | 1942-04-28 | John H Johnson | Device for irrigating and treating wounds |
US4250882A (en) * | 1979-01-26 | 1981-02-17 | Medical Dynamics, Inc. | Wound drainage device |
US6471685B1 (en) * | 2000-05-18 | 2002-10-29 | David James Johnson | Medical dressing assembly and associated method of using the same |
US6648488B1 (en) | 2002-06-14 | 2003-11-18 | Hunter Fan Company | Quick mount lighting assembly for ceiling fans |
US20040054338A1 (en) | 2002-09-13 | 2004-03-18 | Farhad Bybordi | Closed wound drainage system |
US20050148913A1 (en) * | 2004-01-02 | 2005-07-07 | Weston Richard S. | Reduced pressure wound treatment appliance |
US20060116620A1 (en) * | 2004-09-29 | 2006-06-01 | Oyaski Michael F | Wound alternative treatment system |
US20070141128A1 (en) * | 2003-10-28 | 2007-06-21 | Smith & Nephew Plc | Wound cleansing apparatus with actives |
US20070191754A1 (en) * | 2006-02-13 | 2007-08-16 | Adel Aali | Wound shield |
US20080140029A1 (en) | 2006-11-21 | 2008-06-12 | Joshua David Smith | Wound care apparatus |
US20090264838A1 (en) * | 2008-04-21 | 2009-10-22 | Enzysurge Ltd. | Liquid streaming devices for treating wounds, method of making such devices, and method of using such devices for treating wounds |
US7648488B2 (en) | 2005-11-21 | 2010-01-19 | Pioneer Technology, Llc | Wound care system |
US20100160874A1 (en) | 2008-12-24 | 2010-06-24 | Timothy Mark Robinson | Reduced-pressure wound treatment systems and methods employing microstrain-inducing manifolds |
US20110004168A1 (en) * | 2007-05-24 | 2011-01-06 | Applied Tissue Technologies | Wound treatment device employing negative pressure |
WO2011049633A2 (en) | 2009-10-23 | 2011-04-28 | Amir Belson | Portable topical oxygen therapy system |
WO2011087871A2 (en) | 2009-12-22 | 2011-07-21 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
US20120328680A1 (en) | 2011-06-27 | 2012-12-27 | Integrated Healing Technologies, LLC | Wound Treatment Therapy |
US20130053795A1 (en) * | 2011-04-12 | 2013-02-28 | Richard Daniel John Coulthard | Reduced-pressure dressings, systems, and methods with evaporative devices |
US8945030B2 (en) * | 2008-03-12 | 2015-02-03 | Bluesky Medical Group, Inc. | Negative pressure dressing and method of using same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2864414C (en) * | 2012-02-13 | 2021-03-16 | Integrated Healing Technologies | Wound dressing apparatus |
-
2013
- 2013-02-13 CA CA2864414A patent/CA2864414C/en active Active
- 2013-02-13 WO PCT/US2013/025875 patent/WO2013123005A1/en active Application Filing
- 2013-02-13 DK DK13749565.1T patent/DK2814556T3/en active
- 2013-02-13 US US14/378,309 patent/US10695471B2/en active Active
- 2013-02-13 EP EP13749565.1A patent/EP2814556B1/en active Active
-
2020
- 2020-06-30 US US16/917,072 patent/US11517655B2/en active Active
-
2022
- 2022-12-06 US US18/076,181 patent/US20230173162A1/en active Pending
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2280915A (en) * | 1941-04-03 | 1942-04-28 | John H Johnson | Device for irrigating and treating wounds |
US4250882A (en) * | 1979-01-26 | 1981-02-17 | Medical Dynamics, Inc. | Wound drainage device |
US6471685B1 (en) * | 2000-05-18 | 2002-10-29 | David James Johnson | Medical dressing assembly and associated method of using the same |
US6648488B1 (en) | 2002-06-14 | 2003-11-18 | Hunter Fan Company | Quick mount lighting assembly for ceiling fans |
US20040054338A1 (en) | 2002-09-13 | 2004-03-18 | Farhad Bybordi | Closed wound drainage system |
US20070141128A1 (en) * | 2003-10-28 | 2007-06-21 | Smith & Nephew Plc | Wound cleansing apparatus with actives |
US20050148913A1 (en) * | 2004-01-02 | 2005-07-07 | Weston Richard S. | Reduced pressure wound treatment appliance |
US20060116620A1 (en) * | 2004-09-29 | 2006-06-01 | Oyaski Michael F | Wound alternative treatment system |
US7648488B2 (en) | 2005-11-21 | 2010-01-19 | Pioneer Technology, Llc | Wound care system |
US20100121287A1 (en) | 2005-11-21 | 2010-05-13 | Pioneer Technology Llc | Wound care system |
US20070191754A1 (en) * | 2006-02-13 | 2007-08-16 | Adel Aali | Wound shield |
US20080140029A1 (en) | 2006-11-21 | 2008-06-12 | Joshua David Smith | Wound care apparatus |
US8357130B2 (en) | 2006-11-21 | 2013-01-22 | Joshua David Smith | Wound care apparatus |
US20110004168A1 (en) * | 2007-05-24 | 2011-01-06 | Applied Tissue Technologies | Wound treatment device employing negative pressure |
US8945030B2 (en) * | 2008-03-12 | 2015-02-03 | Bluesky Medical Group, Inc. | Negative pressure dressing and method of using same |
US20090264838A1 (en) * | 2008-04-21 | 2009-10-22 | Enzysurge Ltd. | Liquid streaming devices for treating wounds, method of making such devices, and method of using such devices for treating wounds |
US20100160874A1 (en) | 2008-12-24 | 2010-06-24 | Timothy Mark Robinson | Reduced-pressure wound treatment systems and methods employing microstrain-inducing manifolds |
WO2011049633A2 (en) | 2009-10-23 | 2011-04-28 | Amir Belson | Portable topical oxygen therapy system |
WO2011087871A2 (en) | 2009-12-22 | 2011-07-21 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
US8801685B2 (en) * | 2009-12-22 | 2014-08-12 | Smith & Nephew, Inc. | Apparatuses and methods for negative pressure wound therapy |
US20130053795A1 (en) * | 2011-04-12 | 2013-02-28 | Richard Daniel John Coulthard | Reduced-pressure dressings, systems, and methods with evaporative devices |
US20120328680A1 (en) | 2011-06-27 | 2012-12-27 | Integrated Healing Technologies, LLC | Wound Treatment Therapy |
Non-Patent Citations (1)
Title |
---|
Extended European Search Report for European Application No. 13749565.1 dated Jun. 12, 2015. |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11517655B2 (en) * | 2012-02-13 | 2022-12-06 | Phase One Health, Llc | Wound dressing apparatus |
US20230173162A1 (en) * | 2012-02-13 | 2023-06-08 | Phase One Health, Llc | Wound dressing apparatus |
Also Published As
Publication number | Publication date |
---|---|
EP2814556B1 (en) | 2016-12-07 |
WO2013123005A1 (en) | 2013-08-22 |
EP2814556A4 (en) | 2015-07-15 |
EP2814556A1 (en) | 2014-12-24 |
US11517655B2 (en) | 2022-12-06 |
US20210008258A1 (en) | 2021-01-14 |
US20150005678A1 (en) | 2015-01-01 |
US20230173162A1 (en) | 2023-06-08 |
CA2864414A1 (en) | 2013-08-22 |
CA2864414C (en) | 2021-03-16 |
DK2814556T3 (en) | 2017-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11517655B2 (en) | Wound dressing apparatus | |
US20230181813A1 (en) | Multi-modal wound treatment apparatus | |
US9884136B2 (en) | Compositions for treating biofilms and methods for using same | |
ES2675879T3 (en) | Wound care products | |
US8357130B2 (en) | Wound care apparatus | |
US20070118096A1 (en) | Wound care system | |
KR20110063523A (en) | A system and method for delivering reduced pressure to subcutaneous tissue | |
US20200306428A1 (en) | System and methods for the treatment of wounds with negative pressure and instillation of peroxide pyruvic acid | |
CN106794337A (en) | Portable medical treatment system and application method | |
US20220096728A1 (en) | Wound drain | |
UA100923U (en) | METHOD OF TREATMENT OF purulent wounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: INTEGRATED HEALING TECHNOLOGIES, LLC, TENNESSEE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WALL, BILLY RUSSELL;REEL/FRAME:037392/0150 Effective date: 20150210 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
AS | Assignment |
Owner name: PHASE ONE HEALTH, LLC, TENNESSEE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MCLEMORE, JOHN C.;REEL/FRAME:048696/0731 Effective date: 20190227 Owner name: MCLEMORE, JOHN C., TENNESSEE Free format text: COURT APPOINTMENT;ASSIGNOR:INTEGRATED HEALING TECHNOLOGIES, LLC;REEL/FRAME:048697/0451 Effective date: 20180709 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY Year of fee payment: 4 |